Missing/wrong data? Edit Wikidata item
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to most known recently emerging RBD mutations
Author/s
author: Michael Hust, Luka Cicin-Sain, Federico Bertoglio, Maren Bleckmann, Stefan Dübel
Work details
Publication date:
December 3, 2020
Language:
Unknown
Country of origin:
Unknown
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.